Active body cooling with vasodilation to reduce body...

Details Active body cooling with vasodilation to reduce body... Active body cooling with vasodilation to reduce body...

2008-04-22

2008-04-22

Gibson, Roy D. (Department: 3739)

Surgery: light, thermal, and electrical application

Light, thermal, and electrical application

Thermal applicators

C607S096000, C607S108000

Reexamination Certificate

active

10926279

ABSTRACT:
Active cooling of a person, such as to induce mild/moderate hypothermia, is accomplished by transferring heat from the persons body. Heat transfer and patient comfort are aided by administration of an anti-shivering drug and an anti-emetic drug.

REFERENCES:
patent: 4149529 (1979-04-01), Copeland et al.
patent: 5486204 (1996-01-01), Clifton
patent: 5637309 (1997-06-01), Tajima et al.
patent: 6113626 (2000-09-01), Clifton et al.
patent: 6126680 (2000-10-01), Wass
patent: 6197045 (2001-03-01), Carson
patent: 6231594 (2001-05-01), Dae
patent: 6375674 (2002-04-01), Carson
patent: 6468297 (2002-10-01), Williams et al.
patent: 6544282 (2003-04-01), Dae et al.
patent: 6572638 (2003-06-01), Dae et al.
patent: 6582457 (2003-06-01), Dae et al.
patent: 6702839 (2004-03-01), Dae et al.
patent: 6743250 (2004-06-01), Renfro
Alfonsi, P. et al. “The effects of pethidine, fentanyl and lignocaine on postanaesthetic shivering.” Anaesthesia. vol. 50, pp. 214-217, 1995.
Alfonsi, P. et al. “The Effects of Meperidine and Sufentanil on the Shivering Threshold in Postopoerative Patients.” Anethesiology. vol. 89, No. 1, pp. 43-48. Jul. 1998.
Alfonsi, P. “Postanaesthetic Shivering: Epidemiology, Pathophysiology, and Approaches to Prevention and Management.” Drugs. vol. 61, pp. 2193-2205. 2001.
Dawes, Matthew and Ritter, James M. “Mg2+-Induced Vasodilation in Human Forearm Vasculature Is Inhibited by NG-Monomethyl-L-Arginine but Not by Indometacin.” Journal of Vascular Research. vol. 37, pp. 276-281. 2000.
Doufas, A.G. et al. “Dexmedetomidine and Meperidine Additively Reduce the Shivering Threshold in Humans.” Stroke. vol. 34, pp. 1218-1223. 2003.
English, M.M.J. “Heat Exchange Coefficient of the Artic Sun Energy Transfer Pads.” 8 pages. 2003.
Prescott, L. M. “Single-Dose Palonosetron Prevents Emesis for as Long as 40 Hours.” Anesthesiology News. vol. 29, No. 8. 5 pages. Aug. 2003.
Fugate, S.R. et al. “Eclampsia.” www.emedicine.com. EMedicine.com, Inc. 16 pages. 2003.
Gadegbeku, C.A. et al. “Hemodynamic Effects of Nicotinic Acid Infusion in Normotensive and Hypertensive Subjects.” The American Journal of Hypertension, Ltd. vol. 16, pp. 67-71. 2003.
Goodin, S. and Cunningham, R. 5-HT3-Receptor Antagonists for the Treatment of Nausea and Vomiting: A Reappraisal of Their Side-Effect Profile. The Oncologist. vol. 7, pp. 424-436. 2002.
Guffin, A. et al. Shivering Following Cardiac Surgery: Hemodynamic Changes and Reversal. Journal of Cardiothoracic Anesthesia. vol. 1, No. 1. pp. 24-28. Feb. 1987.
Ikeda, T. et al. “The Effect of Opioids on Thermoregulatory Responses in Humans and the Special Antishivering Action of Meperidine.” Annals New York Academy of Sciences. 15;813: pp. 792-798. 1997.
Ikeda, T. et al. “Meperidine and Alfentanil Do Not Reduce the Gain or Maximum Intensity of Shivering.” Anesthesiology. vol. 88, No. 4, pp. 858-865. Apr. 1998.
Katzman, M. et al. “Methyl Nicotinate-Induced Vasodilation in Generalized Social Phobia.” Neuropsychopharmacology. vol. 28, pp. 1846-1851. 2003.
Kawamura, S. et al. “Hypothermia Bed System for Stroke Patients.” Neurol Med Chir (Tokyo). vol. 39, pp. 466-470. 1999.
Kizilirmak, S. et al. “Magnesium Sulfate Stops Postanesthetic Shivering.” Annals of the New York Academy of Sciences. vol. 813, pp. 799-806. Mar. 15, 1997.
Knoll, T. et al. “The Low Normothermia Concept—Maintaining a Core Body Temperature Between 36 and 37° C. in Acute Stroke Unit Patients.” Journal of Neurosurgical Anesthesiology. vol. 14, No. 4, pp. 304-308. 2002.
Kranke, P. et al. “Pharmacological Treatment of Postoperative Shivering: A Quantitative Systematic Review of Randomized Controlled Trials.” Anesth Analg. vol. 94. pp. 453-460. 2002.
Kurz, A. et al. “Thermoregulatory Vasoconstriction Impairs Active Core Cooling.” Anesthesiology. vol. 82, No. 4, pp. 870-876. 1995.
Kurz, A. et al. “Meperidine Decreases the Shivering Threshold Twice as Much as the Vasoconstriction Threshold.” Anesthesiology. vol. 86, No. 5, pp. 1046-1054. May 1997.
Kyriakides, K. et al. “Management of opiod-induced pruritus: a role for 5-HT3antagonists?” British Journal of Anaesthesia. vol. 82, pp. 439-441. 1999.
“Meperdine”. Clinical Pharmacology. 25 pages. 2000.
Mokhtarani, M. et al. “Buspirone and Meperidine Synergistically Reduce the Shivering Threshold.” vol. 93, pp. 1233-1239. 2001.
Morrow, J.D. et al. “Identification of Skin as a Major Site of Prostaglandin D2 Release Following Oral Administration of Niacin in Human.” vol. 98, No. 5, pp. 812-815. 1992.
Muir, K.W. “Magnesium in stroke treatment.” Postgrad Med J. vol. 78, pp. 641-645. 2002.
Olson, James M.Clinical Pharmacology Made Ridiculously Simple. MedMaster, Inc. pp. 30, 31, 52-55. 1998.
Pauca, A.L. et al. “Effect of Pethidine, Fentanyl and Morphine on Post-Operative Shivering in Man.” Acta Anaesthesiol Scand. vol. 28, pp. 138-143. 1984.
Powell, R.M. and Buggy, D.J. “Ondansetron Given Before Induction of Anesthesia Reduces Shivering After General Anesthesia.” Anesth Analg. vol. 90, pp. 1423-1427. 2000.
Schmid-Elsaesser, R. et al. “Combination Drug Therapy and Mild Hypothermia A Promising Treatment Strategy for Reversible, Focal Cerebral Ischemia.” Stroke. vol. 30, pp. 1891-1899. Sep. 1999.
Svedmyr, N. et al. “The relationship between the plasma concentration of free nicotinic acid and some of its pharmacologic effects in man.” Clinical Pharmacology and Therapeutics. vol. 10, No. 4, pp. 559-570. 1969.
Suleman, M.I. et al. “Dexmedetomidine and Meperidine Additively Reduce the Shivering Threshold.” Anesthesiology. vol. 96, p. A-311. 2002.
Wilkin, J.K. et al. “Prostaglandins and nicotinate-provoked increase in cutaneous blood flow.” Clin Pharmacol. Ther. vol. 38, No. 3, pp. 273-277. Sep. 1985.
“ZOFRAN® (ondansetron hydrochloride) Injection ZOFRAN® (ondansetron hydrochloride) Injection Premixed.” Product Information. GlaxoWellcome Inc. 19 pages. 2000.
“ZOFRAN® (ondansetron hydrochloride) Tablets ZOFRAN® (ondansetron). Orally Disintegrating Tablets ZOFRAN® (ondansetron hydrochloride) Oral Solution.” Product Information. GlaxoSmithKline. 14 pages. 2001.
Zweifler, R.M. and Sessler, D.I. “Thermoregulatory Vasoconstriction and Shivering Impede Therapeutic Hypothermia in Acute Ischemic Stroke Patients.” Journal of Stroke and Cerebrovascular Diseases. vol. 6, No. 2, pp. 100-104. 1996.
Zweifler, R.M. et al. “Induction and Maintenance of Mild Hypothermia by Surface Cooling in Non-intubated Subjects.” Journal of Stroke and Cerebrovascular Diseases. vol. 12, No. 5. pp. 237-243. 2003.
Zweifler, R.M. et al. “Magnesium Sulfate Increases the Rate of Hypothermia Via Surface Cooling and Improves Comfort.” Stroke. vol. 35, pp. 2331-2334. 2004.
Zweifler, R.M. et al. “A Novel Method to Induce Mild Hypothermia Via Surface Cooling.” American Academy of Neurology 53rdAnnual Meeting, Philadelphia, Pennyslvania, May 5-11, 2001. 5 pages.

Affiliated with

Also associated with

Rating

Active body cooling with vasodilation to reduce body... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Active body cooling with vasodilation to reduce body..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Active body cooling with vasodilation to reduce body... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3956864